Prosensa Investors

35 investors on Angel Roster list Prosensa in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, the United Kingdom and France.

Investors are matched on the company name in their portfolio, so companies that share the name Prosensa can appear together.

Investors listed
35
With verified email
34%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 35 Prosensa investors

The most complete profiles first. Showing 35 of 35.

  • Ken HaasVerified

    Venture Capital, Advisor, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • andrew sinclairVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Arnaud PersynVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • David MottVerified

    Venture Capital, Angel/Individual, Investor · United States

    SeedPre-SeedEnterprise SoftwareBiotechnologyHealth and Hospital ServicesConsumer Internet

    Portfolio: Nightstar Therapeutics, Ardelyx, Cydan, Adaptimmune and 4 more

    Verified email available

  • FrançoisVerified

    Venture Capital, Private Equity Firm · France

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • Guillaume BardyVerified

    Venture Capital, Private Equity Firm · France

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • Hidde Van KerckhovenVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • Kevin KleinVerified

    Venture Capital, Private Equity Firm · France

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • Maja MarkovicVerified

    Venture Capital, Private Equity Firm · Germany

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • MarieVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Verified email available

  • Shelley ChuVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Tim HainesVerified

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Verified email available

  • Bali Muralidhar

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more

    Contact details available

  • Brian Gallagher, Jr.

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more

    Contact details available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Kurt von Emster

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedInvestment ManagementLife Science

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Vin Miles

    Venture Capital, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Anne Caron

    Venture Capital, Private Equity Firm · France

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Charles Le Texier

    Venture Capital, Private Equity Firm · France

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Ferdinand Becker

    Venture Capital, Private Equity Firm · Germany

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Gert Kerkstoel

    Venture Capital, Private Equity Firm · United States

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • John Heard

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Maxence Kasper

    Venture Capital, Private Equity Firm · France

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Merijn Klaassen

    Private Equity Firm · Netherlands

    Health CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Michaël Vlemmix

    Venture Capital, Private Equity Firm · Belgium

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Niklas Windmann

    Venture Capital, Private Equity Firm · Germany

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Philipp von Hammerstein

    Venture Capital, Private Equity Firm · Germany

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Roland Veldhuijzen van Zanten

    Venture Capital, Private Equity Firm · Netherlands

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Ruben Monballieu

    Venture Capital, Private Equity Firm · Belgium

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Sarah Shackelton

    Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more

    Contact details available

  • Thomas Goudriaan

    Venture Capital, Private Equity Firm · Netherlands

    Health CareEnergyChemicalLife Science

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

  • Thomas Harth

    Venture Capital, Private Equity Firm · United States

    Health CareEnergyChemicalEducation

    Portfolio: GOVECS, Inside Secure, Legallais, Easyvoyage and 74 more

    Contact details available

Frequently asked questions

How many Prosensa investors are on Angel Roster?

Angel Roster lists 35 Prosensa investors. 12 of them (34%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (33), Private Equity Firms (28) and Angel Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Prosensa investors invest in?

Among those that list a stage, the most common are Series B (9), Seed (2) and Pre-Seed (1).

Where are Prosensa investors based?

Most are based in the United States (11), the United Kingdom (6) and France (6).

Which companies have Prosensa investors backed?

The most-backed portfolio companies among them are Pronota (24), GTX medical (24), ActoGeniX (24), ImCheck Therapeutics (24) and RES Software (19).

How do I contact Prosensa investors?

Create a free Angel Roster account to search and filter all 35, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.